PubMed COVID-19 Clinical Care

A mix of guidance and mandated regulations during the coronavirus disease (COVID-19) pandemic served to reduce the number of social contacts, to ensure distancing in public spaces, and to maintain the isolation of infected individuals. Individual

Remdesivir has appeared to be the most effective medication against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and is broadly administered to coronavirus disease 2019 (COVID-19) patients around the world. Remdesivir is

CONCLUSIONS: First-generation students reported elevated levels of COVID impact even when reporting high levels of growth, while posttraumatic growth buffered impact among non-first-generation students. Results support the need for targeted college

CONCLUSION: The level and type of fatigue was affected by the severity of the disease. However, the disease process itself represented by the levels of the inflammatory markers showed little influence on fatigue. The implications such as continuous

CONCLUSIONS: Despite COVID-19 interrupting scheduled market service, the length of time that a survey respondent identified as a full-service mobile market customer was associated with higher food access and fruit/vegetable intake and reduced food

Societies often respond to a crisis by attributing blame to some groups while constructing others as victims and heroes. While it has received scant sociological attention, 'panic buying' is a critical indicator of such public sentiment at the onset

We aimed to understand clinician perspectives on mental healthcare delivery during COVID-19 and the utility of tele-mental health services in carceral settings. A survey was administered in November 2022 through the American College of Correctional

COVID-19 is an epidemic disease that has threatened all the people at worldwide scale and eventually became a pandemic It is a crucial task to differentiate COVID-19-affected patients from healthy patient populations. The need for technology enabled

CONCLUSIONS: In critically ill COVID-19, HDMB significantly increases the risk of IAP whereas DXM alone, nor in combination with tocilizumab, did not.

The COVID-19 pandemic has highlighted the potential impact of this disease on cardiovascular morbidity and mortality. Patients with established cardiovascular (CV) disease are at increased risk of severe infection and hospital-acquired adverse